Product logins

Find logins to all Clarivate products below.


Pain Management Devices – Market Insights – Europe (Supplemental)

The European pain management space remains active, with manufacturers continuing to innovate and work toward receiving regulatory approval for new indications, supporting market growth in Europe. Additionally, the prevalence of chronic pain is increasing, which will further support market growth. However, the European healthcare system remains constrained, and hence the European pain management device market is expected to see moderate growth through 2033.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for pain management devices in Europe from 2019 through 2033.

Table of contents


Related Medtech Insights Reports

Report
Interventional Oncology Devices – Market Insights – Latin America
The Latin American interventional oncology device market will see moderate growth through 2034, driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of…
Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…
Report
Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific diabetes care device market is expected to experience moderate growth over the forecast period, driven by a rising diabetes population, untapped market opportunities, regulatory…
Report
Heart Valve Devices – Market Insights – United States
The US heart valve device market continues to be driven by the introduction of novel products and key approvals for new indications of existing products. In particular, recent approvals of…